SCHEMBL25168230

SCHEMBL25168230

COc1ccc(CC(NC(=O)[C@@H](NC(=O)OC(C)(C)C)[C@@H](C)OC(C)(C)C)C(=O)N2CCCC2(C)C(=O)O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTRA1 Q92743 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ MMP1 P03956 6/20 0.38
▸ PPARG P37231 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ HRH2 P25021 1/20 0.37
▸ HRH1 P35367 1/20 0.37
▸ PSMB8 P28062 2/20 0.36
▸ PSMB5 P28074 2/20 0.36
▸ CACNA1B Q00975 1/20 0.36
▸ PSMA1 P25786 1/20 0.36
▸ PSMB9 P28065 1/20 0.36
▸ PSMB4 P28070 1/20 0.36
▸ PSMB10 P40306 1/20 0.36
▸ ITGB3 P05106 1/20 0.36
▸ ITGA2B P08514 1/20 0.36
▸ MMP3 P08254 3/20 0.36
▸ MMP9 P14780 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23537868 1.00 HTRA1 (0.40) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25168228 1.00 HTRA1 (0.40) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25495877 1.00 HTRA1 (0.40) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25168229 1.00 HTRA1 (0.40) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25495881 0.94 HTRA1 (0.40) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25444832 0.93 HTRA1 (0.44) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25171447 0.92 PSMB10 (0.42) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25171446 0.92 PSMB10 (0.42) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25171448 0.92 PSMB10 (0.42) HTRA1ALDH1A1LMNAKMT2AMMP1
SCHEMBL25500045 0.91 MMP1 (0.40) MMP1PSMB8PSMB5PSMA1PSMB9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577259-B2 PCSK9 antagonist compounds MERCK SHARP & DOHME LLC (US) 2026-03-17 — — US disclosed
US-20230144324-A1 PCSK9 ANTAGONIST COMPOUNDS MERCK SHARP & DOHME LLC 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577259-B2 PCSK9 antagonist compounds PCSK9, LDLR, PCSK6 HTRA1 735/4885ALDH1A1 4460/4885LMNA 395/4885
US-20230144324-A1 PCSK9 ANTAGONIST COMPOUNDS PCSK9, PCSK7, PCSK6 HTRA1 103/4885ALDH1A1 2378/4885LMNA 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback